Allogene Therapeutics (ALLO) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.33
-0.3
-0.26
-0.23

Details

Expected EPS
-0.267655
Actual EPS
-0.23
Surprise EPS
0.04
Surprise Percent
+14.07%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.23 per share for Q3 2025.

0 Comments

Share your thoughts